The world is dealing with the COVID-19 issue by throwing everything it has at the Bioweapon that has killed thousands per day and lakhs millions so far.
The battle has been tough with losing the lives of our loved ones, seeing them suffer from pain and near-death experience is dreadful. The battle is getting difficult with the new types of infection attacking your body when you are COVID 19 positive like Black Fungus and White Fungus.
In times like this, we shift to the vaccines to stop getting ourselves infected with the Corona Virus. Below are the types of vaccines present in the market:
- Covaxin: Bharat Biotech International Limited of Hyderabad produced an inactivated vaccine in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology in Pune. It’s structured on a tested foundation of dead viruses. The vaccine contains a dead COVID -19 virus.
- Covishield: It is constructed on a viral vector platform, the ChAdOx1 chimp adenovirus (the vector). It is developed by the Serum Institute of India and manufactured by AstraZeneca. As per the ICMR head, Covishield’s first dose develops strong immunity than Covaxin’s. This virus is used for infections like Ebola.
- Sputnik V: It’s based on a well-proven and well-studied platform of human adenoviral vectors, which have been around for thousands of years and cause the common cold. It is developed by The Gamaleya Research Institute of Epidemiology and Microbiology, Russia. The WHO has not yet approved the vaccine, and it is not part of the worldwide COVAX project.
Sputnik V uses two distinct vectors for each of the two doses in a vaccination course, resulting in longer-lasting protection than vaccines that employ the same delivery mechanism for both doses. Sputnik V does not cause any severe allergies.
Points to Ponder on:
- Typically, all three immunizations are administered two days apart, 28-45 days apart.
- Covaxin has an effectiveness of 81.6 per cent. The efficacy of Covishield varies between 70 and 90 per cent, depending on the time interval between two doses given to patients. While the Sputnik V vaccine has a 97.6 per cent effectiveness rate.
COVID-19 Vaccines at the trial stages in India?
Vaccines that are currently being tested for safety and efficacy in India include:
- ZyCov-Di, being developed by Ahmedabad’s Zydus Cadila In India. It is based on the DNA vaccine system.
- A vaccine being produced by Biological E, the first Indian private vaccine manufacturer, in partnership with US-based Dynavax and Baylor College of Medicine.
- Hyderabad-based Biological E is also producing a vaccine developed by Johnson & Johnson, a US firm.
- HGCO19 is India’s first mRNA vaccine, developed by Pune-based Genova in conjunction with Seattle-based HDT Biotech Corporation. It works by inducing an immune response with bits of genetic code.
- Bharat Biotech has been developing a nasal vaccination.
- Serum Institute of India and Novavax, an American vaccine development business, are working on a second vaccine.
Due to a lack of availability or restricted inventories, people in India are still unable to choose a vaccine of their choice. So far, India has administered over 17 crore total doses. Therefore, wait no more, get yourself and your loved ones vaccines shots today.